The Latest Breaking News from FDA

A 19th century “anti-vice” law is at the center of a new court ruling that threatens access to the leading abortion drug in the U.S. Dormant for a half-century, the Comstock Act is being been revived by groups seeking to block the mailing of mifepristone, the pill used in more…

Texas judge presiding over several cases with far-reaching national implications

The case would affect women all over the country, making abortions harder to access even in states where it’s legal.

The pharmaceutical firm said it is confident the jabs for cancer could be ready by the end of the decade

Some doctors prescribe sublingual immunotherapy, known as SLIT, a serum taken as drops under the tongue. Patients like it, but it is not FDA-approved, so insurance usually doesn't cover it.

‘It is up to the Biden administration... to choose whether or not to enforce such a ruling’

Access to the most commonly used method of abortion in the U.S. plunged into uncertainty Friday following conflicting court rulings over the legality of the abortion medication mifepristone that has been widely available for more than 20 years.

ATLANTA — A federal judge in Texas delivered a major blow to reproductive rights advocates Friday, ordering a hold on the Food and Drug Administration approval of mifepristone, an abortion medication used in the United States since 2000.

The most common abortion method in the U.S. is at risk of disappearing from the market, at least temporarily, after a Texas judge granted an injunction against the U.S. Food and Drug Administration’s decades-old approval for mifepristone, also known as the abortion pill.